A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
Clinical trial NCT01090427 · COMPLETED
Trial details
- NCT number
- NCT01090427
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.